Laboratorio Reig Jofre, S.A.

BME:RJF Rapport sur les actions

Capitalisation boursière : €219.4m

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Laboratorio Reig Jofre Croissance future

Future contrôle des critères 4/6

Laboratorio Reig Jofre devrait augmenter ses bénéfices et son chiffre d'affaires de 24.4% et de 8.2% par an respectivement. Le BPA devrait croître de de 22.8% par an. Le rendement des capitaux propres devrait être 6.9% dans 3 ans.

Informations clés

24.4%

Taux de croissance des bénéfices

22.8%

Taux de croissance du BPA

Pharmaceuticals croissance des bénéfices15.3%
Taux de croissance des recettes8.2%
Rendement futur des capitaux propres6.9%
Couverture par les analystes

Low

Dernière mise à jour30 Jul 2024

Mises à jour récentes de la croissance future

Recent updates

Calculating The Fair Value Of Laboratorio Reig Jofre, S.A. (BME:RJF)

Jun 22
Calculating The Fair Value Of Laboratorio Reig Jofre, S.A. (BME:RJF)

These 4 Measures Indicate That Laboratorio Reig Jofre (BME:RJF) Is Using Debt Extensively

Feb 02
These 4 Measures Indicate That Laboratorio Reig Jofre (BME:RJF) Is Using Debt Extensively

This Analyst Just Downgraded Their Laboratorio Reig Jofre, S.A. (BME:RJF) EPS Forecasts

Mar 07
This Analyst Just Downgraded Their Laboratorio Reig Jofre, S.A. (BME:RJF) EPS Forecasts

We Think Laboratorio Reig Jofre (BME:RJF) Is Taking Some Risk With Its Debt

Mar 07
We Think Laboratorio Reig Jofre (BME:RJF) Is Taking Some Risk With Its Debt

Laboratorio Reig Jofre (BME:RJF) Seems To Use Debt Quite Sensibly

May 17
Laboratorio Reig Jofre (BME:RJF) Seems To Use Debt Quite Sensibly

The Laboratorio Reig Jofre (BME:RJF) Share Price Has Gained 146%, So Why Not Pay It Some Attention?

Mar 07
The Laboratorio Reig Jofre (BME:RJF) Share Price Has Gained 146%, So Why Not Pay It Some Attention?

Is Laboratorio Reig Jofre (BME:RJF) Using Too Much Debt?

Jan 14
Is Laboratorio Reig Jofre (BME:RJF) Using Too Much Debt?

Laboratorio Reig Jofre (BME:RJF) Shareholders Booked A 47% Gain In The Last Year

Dec 05
Laboratorio Reig Jofre (BME:RJF) Shareholders Booked A 47% Gain In The Last Year

Prévisions de croissance des bénéfices et des revenus

BME:RJF - Estimations futures des analystes et données financières antérieures (EUR Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/2026408179351
12/31/2025379156311
12/31/2024349115241
6/30/20243349-316N/A
3/31/20243269N/AN/AN/A
12/31/20233189619N/A
9/30/202331612N/AN/AN/A
6/30/202329810618N/A
3/31/202328610N/AN/AN/A
12/31/20222748516N/A
9/30/20222624N/AN/AN/A
6/30/20222565-65N/A
3/31/20222453N/AN/AN/A
12/31/20212405-514N/A
9/30/20212376N/AN/AN/A
6/30/20212345922N/A
3/31/20212346N/AN/AN/A
12/31/20202346719N/A
9/30/20202298N/AN/AN/A
6/30/20202296-1514N/A
3/31/20202196N/AN/AN/A
12/31/20192065-1912N/A
9/30/20191997N/AN/AN/A
6/30/20191889-1016N/A
3/31/20191889N/AN/AN/A
12/31/20181859-615N/A
9/30/201818510N/AN/AN/A
6/30/20181799-414N/A
3/31/20181759N/AN/AN/A
12/31/20171729N/A21N/A
9/30/20171645N/AN/AN/A
6/30/20171647N/A8N/A
3/31/20171648N/AN/AN/A
12/31/20161618N/A-1N/A
9/30/20161605N/AN/AN/A
6/30/20161595N/A8N/A
3/31/20161565N/AN/AN/A
12/31/20151579N/A13N/A
12/31/20141339N/A-13N/A
9/30/20141229N/A12N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: RJF's forecast earnings growth (24.4% per year) is above the savings rate (1.7%).

Bénéfices vs marché: RJF's earnings (24.4% per year) are forecast to grow faster than the Spanish market (9.6% per year).

Croissance élevée des bénéfices: RJF's earnings are expected to grow significantly over the next 3 years.

Chiffre d'affaires vs marché: RJF's revenue (8.2% per year) is forecast to grow faster than the Spanish market (4.7% per year).

Croissance élevée des revenus: RJF's revenue (8.2% per year) is forecast to grow slower than 20% per year.


Prévisions de croissance du bénéfice par action


Rendement futur des capitaux propres

ROE futur: Le retour sur capitaux propres de RJF devrait être faible dans 3 ans ( 6.9 %).


Découvrir les entreprises en croissance